Scouting report · HELP
#23Greg Cavers
CFO of Cybin/Helus Pharma since the November 2020 listing
- Born / age
- (56)
- Role
- Chief Financial Officer
- In the role
- 6 yr
- Education
- CA (Chartered Accountant designation) Not stated
- Front Office rank
- #23 of 23
HELP
Stake value$260k0.03% · 18,987 shares · as of 29 Jun 2026
D49 / 100
Scouting sheetas of 24 Sep 2026
Delivers guidance640 beat · 4 met · 0 missed · 1 withdrawn
Answers the question—no call reviewed yet
Capital allocation60company five-year record: neutral
Pay design10individual, time only · company lost money
Skin in the game33stake worth $260k, 0.2× last year's pay
80%Hit rate
—Pay at risk
—Say-on-pay
—Airtime on calls
- Beat
- 0
- Met
- 4
- Missed
- 0
- Withdrawn
- 1
- Still open
- 2
- Answers on calls
- 0
- Questions dodged
- 0
- Dodges / 100 answers
- —
Personal and ownership data
What to weigh
Watch 2
- Owns 18,987 shares (0.03%) excluding 83,334 unvested RSUs, the smallest direct stake of the listed officers, after almost six years as CFO; the company has no formal ownership guidelinesrc
- Came from the CFO chair of a CSE-listed company under a cease-trade order for missed filings (LottoGopher); the order predates himsrc
In their favour 1
- Continuity: the FY2026 CFO certification and the written milestone record in the dossier's S8 were signed under himsrc
Pay
Salary and otherBonus, stock, options, incentive
The table
- Bonus pays on
- Discretionary cash bonus against objectives the Compensation Committee sets each year; $225,000 paid for FY2026
- Long-term award pays on
- RSU grant ($598,000 in FY2026) with no performance condition disclosed; earlier years in optionssrc
- Pay at risk not on file
- Pays on returns individual, time only
- Shareholder vote not on file
- Pay vs profit company lost money
Career
- 2020-11 – nowCybin Inc. (Helus Pharma)src
Chief Financial Officer
Signed the 2021 Form 40-F registration as CFO (40FR12B-2021) and certifies the FY2026 annual filing (CERT-CFO-FY26); has served under every CEO and interim CEO since, from founding CEO Paul Glavine to Michael Halstead - 2019-02 – 2020-01LottoGopher Holdings Inc. (CSE)src
Chief Financial Officer and director (described in the AIF as interim CFO)
End date January 2020 from AIF-FY26
Undated in the sources
- CST Industries; Scotiabank; TD; CIBCsrc, VP Finance (CST Industries); Senior Manager Enterprise Functions (Scotiabank); Private Investment Advisor (TD); Retail Small Business Lending Controller and Director of Merchant Banking Finance (CIBC)
Not located: Everything before February 2019 is undated: the bank and CST Industries roles come only from a search summary of his own LinkedIn profile, and no Cybin filing read gives his pre-2020 career
The promise ledger5 scored · 2 open
| Result | What was promised | Where it is scored | How |
|---|---|---|---|
| M Met | Repay indebtedness — $22,765 out of the October 2025 offering | HELP row 1 | written outlook |
| M Met | Initiate enrollment in EMBRACE — $1,196 | HELP row 2 | written outlook |
| M Met | Complete the Phase 2 GAD study — $1,292 | HELP row 3 | written outlook |
| M Met | Provide topline data from the Phase 2 GAD study — $810 | HELP row 4 | written outlook |
| W Withdrawn | ❗ HLP005 — deliver a drug development candidate by Q4 2026 | HELP row 5 | written outlook |
| · Still open | APPROACH topline efficacy readout in Q4 2026 (~$49,857 total, $23,686 remaining at 2026-03-31) | HELP row 6 | written outlook |
| · Still open | HLP004 — complete the design of the next study by the end of Q3 2026 (~$150, none spent at 2026-03-31) | HELP row 7 | written outlook |
Background
- Regulatory Interim CFO of LottoGopher Holdings until January 2020; LottoGopher had been cease-traded on 2018-12-05 for failing to file interim financials, MD&A and certifications, before he took the rolesrc
- Other Employment agreement gives 12 months' notice on termination without cause plus one month per completed year of servicesrc
Sources7
- Filing Cybin Inc. Annual Information Form for the year ended 2026-03-31, dated 2026-06-29 (Ex-99.1 to 40-F, acc 0001833141-26-000046) · 2026-06-29
- Filing Cybin Inc. management information circular for the 2026 annual and special meeting, dated 2026-08-18 (Ex-99 to 6-K, acc 0001833141-26-000067) · 2026-08-18
- Filing Cybin Inc. audited consolidated financial statements FY ended 2026-03-31 (Ex-99.2 to 40-F, acc 0001833141-26-000046) · 2026-06-29
- Filing Cybin Inc. 40-F FY2026, Ex-99.5 CFO certification signed by Greg Cavers · 2026-06-29
- Filing Cybin Inc. Form 40-F registration statement, signed by Greg Cavers as CFO (acc 0001193125-21-224423) · 2021-07-26
- Web search result WebSearch: LottoGopher Holdings announces board and management update (Newsfile, 2019-02-13): Cavers appointed director and CFO · 2026-09-24
- Web search result WebSearch: Greg Cavers CA., LinkedIn profile as summarised by the search tool (CIBC, TD, Scotiabank, CST Industries, LottoGopher roles; no dates) · 2026-09-24